Amicus Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 02/12/2026 | 32.52 M | $463.15 M | 25.82% | 10.54% |
| VANGUARD GROUP INC | 01/29/2026 | 29.70 M | $422.97 M | 0.57% | 9.63% |
| HBK INVESTMENTS L P | 02/17/2026 | 15.25 M | $217.16 M | 100.00% | 4.94% |
| STATE STREET CORP | 02/13/2026 | 14.83 M | $211.23 M | 28.28% | 4.81% |
| PENTWATER CAPITAL MANAGEMENT LP | 02/17/2026 | 11.50 M | $163.76 M | 100.00% | 3.73% |
| BELLEVUE GROUP AG | 02/17/2026 | 10.74 M | $152.87 M | 100.00% | 3.48% |
| WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 02/09/2026 | 10.63 M | $151.34 M | -32.52% | 3.45% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 7.35 M | $104.62 M | 3.47% | 2.38% |
| PERCEPTIVE ADVISORS LLC | 02/17/2026 | 6.37 M | $90.72 M | 0.00% | 2.07% |
| GOLDMAN SACHS GROUP INC | 03/25/2026 | 6.14 M | $87.48 M | 62.33% | 1.99% |
| UBS GROUP AG | 01/29/2026 | 5.89 M | $83.92 M | 240.48% | 1.91% |
| MORGAN STANLEY | 02/13/2026 | 5.48 M | $78.03 M | 71.31% | 1.78% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/12/2026 | 5.21 M | $74.15 M | 11.03% | 1.69% |
| PALO ALTO INVESTORS LP | 02/17/2026 | 5.21 M | $74.13 M | -3.02% | 1.69% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/17/2026 | 5.12 M | $72.97 M | 272.13% | 1.66% |
| CITADEL ADVISORS LLC | 02/17/2026 | 5.10 M | $72.58 M | -38.22% | 1.65% |
| MACQUARIE MANAGEMENT HOLDINGS, INC. | 02/17/2026 | 5.07 M | $72.19 M | 100.00% | 1.64% |
| SOROS FUND MANAGEMENT LLC | 02/13/2026 | 5.00 M | $71.20 M | 100.00% | 1.62% |
| NUVEEN, LLC | 02/12/2026 | 4.63 M | $65.91 M | 0.13% | 1.50% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 4.43 M | $63.15 M | 153.47% | 1.44% |
| MAGNETAR FINANCIAL LLC | 02/17/2026 | 3.97 M | $56.50 M | 100.00% | 1.29% |
| JPMORGAN CHASE & CO | 02/11/2026 | 3.72 M | $52.94 M | 75.67% | 1.21% |
| RICE HALL JAMES & ASSOCIATES, LLC | 02/17/2026 | 3.51 M | $49.98 M | 2.18% | 1.14% |
| DEUTSCHE BANK AG\ | 02/11/2026 | 3.46 M | $49.23 M | 39.37% | 1.12% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 3.44 M | $48.96 M | -51.64% | 1.11% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 3.00 M | $42.65 M | -74.64% | 0.97% |
| KRYGER CAPITAL LTD | 02/17/2026 | 2.99 M | $42.64 M | 100.00% | 0.97% |
| TIG ADVISORS, LLC | 02/17/2026 | 2.93 M | $41.69 M | 100.00% | 0.95% |
| ALLIANCEBERNSTEIN L.P. | 02/17/2026 | 2.71 M | $38.61 M | 648.13% | 0.88% |
| NORTHERN TRUST CORP | 02/17/2026 | 2.64 M | $37.65 M | -20.77% | 0.86% |
| BLACKSTONE INC. | 02/17/2026 | 2.57 M | $36.66 M | 4.34% | 0.83% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/13/2026 | 2.56 M | $36.48 M | -6.92% | 0.83% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 2.25 M | $32.06 M | 23.92% | 0.73% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/17/2026 | 2.07 M | $29.45 M | -71.10% | 0.67% |
| PICTET ASSET MANAGEMENT HOLDING SA | 01/29/2026 | 1.99 M | $28.43 M | -70.61% | 0.65% |
| AQR ARBITRAGE LLC | 02/17/2026 | 1.98 M | $28.24 M | 100.00% | 0.64% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/17/2026 | 1.93 M | $27.48 M | -0.90% | 0.63% |
| WEISS ASSET MANAGEMENT LP | 02/17/2026 | 1.89 M | $26.95 M | 100.00% | 0.61% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 02/17/2026 | 1.85 M | $26.34 M | 4,110.86% | 0.60% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/17/2026 | 1.65 M | $23.50 M | 100.00% | 0.53% |
| CITIGROUP INC | 02/13/2026 | 1.65 M | $23.48 M | 1,368.52% | 0.53% |
| SAND GROVE CAPITAL MANAGEMENT LLP | 02/17/2026 | 1.65 M | $23.45 M | 100.00% | 0.53% |
| GLAZER CAPITAL, LLC | 02/13/2026 | 1.60 M | $22.84 M | 100.00% | 0.52% |
| D. E. SHAW & CO., INC. | 02/17/2026 | 1.55 M | $22.06 M | -59.96% | 0.50% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/17/2026 | 1.49 M | $21.18 M | -11.86% | 0.48% |
| ALLIANZ ASSET MANAGEMENT GMBH | 02/11/2026 | 1.49 M | $21.17 M | 282.15% | 0.48% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 1.47 M | $20.98 M | 51.13% | 0.48% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/17/2026 | 1.37 M | $19.56 M | -95.20% | 0.45% |
| STEPHENS INVESTMENT MANAGEMENT GROUP LLC | 02/05/2026 | 1.35 M | $19.25 M | 7.23% | 0.44% |
| WOODLINE PARTNERS LP | 02/17/2026 | 1.29 M | $18.30 M | 15.74% | 0.42% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amicus Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 488 institutional investors and hedge funds held shares of Amicus Therapeutics Inc. The most heavily invested institutionals were:
UBS Group AG: 15.96 M
CITIGROUP INC: 4.23 M
Nuveen, LLC: 2.3 M
VANGUARD FIDUCIARY TRUST CO: 2.14 M
BNP PARIBAS ARBITRAGE, SNC: 1.86 M
CIBRA Capital Ltd: 1.69 M
104.03% of Amicus Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 396.45 M shares in the last 24 months. This purchase volume represents approximately $5.70 B in transactions.